all news

Our partners are building great companies. We love to share their stories.

Wed, 4 Mar 2026 GlobeNewswire

Lifecore Biomedical Signs New Agreement with Indomo to Support Innovative Drug/Device Combination Acne Treatment

Wed, 4 Mar 2026 Business Wire

Arsenal Medical Announces First Patient Treated with ResQFoam for Life-Threatening Abdominal Bleeding

Tue, 3 Mar 2026 pathai.com

PathAI Receives U.S. FDA Breakthrough Device Designation for PathAssist Derm, an AI-Powered Pathology Solution to Transform Dermatopathology

Fri, 27 Feb 2026 Ticker Report

Tectonic Therapeutic Spotlights TX2100 in HHT as First-in-Human Phase 1 Dosing Begins

Tue, 24 Feb 2026 BioSpace

QurAlis Demonstrates Effects on Disease Progression and Target Engagement in ANQUR Clinical Trial of QRL-201, a First-in-Class Precision Medicine in Development for Sporadic ALS

Wed, 18 Feb 2026 Global HR Reporter

Cyclerion Therapeutics Announces Progress Toward CYC-126 Phase 2 Proof-of-Concept Study with FDA Feedback and Formation of Clinical Advisory Board

Wed, 11 Feb 2026 Dewpoint Therapeutics

Dewpoint Therapeutics Selects First-in-Class MYC Condensate Modulator Development Candidate

Wed, 4 Feb 2026 Dewpoint Therapeutics

Dewpoint Therapeutics Doses First Patient in Phase 1a/2a Trial DPTX3186 for the Treatment of Advanced Solid Tumors, Focused on Gastric Cance

Wed, 28 Jan 2026 Business Wire

TRexBio Closes $50 Million Financing to Support a Growing Clinical-Stage Immunology Pipeline of Tissue-Targeted Treg Therapeutics

Mon, 26 Jan 2026 Yahoo! Finance

Primmune Therapeutics Announces Additional Close of Series B Financing

Tue, 20 Jan 2026 Yahoo! Finance

FloQast Hits $200 Million ARR Milestone, Driven by Enterprise Momentum and Adoption of its Auditable AI Agents

Mon, 12 Jan 2026 Associated Press

Freenome Announces Expanded Artificial Intelligence and Deep Learning Initiatives Accelerated by NVIDIA, to Advance Personalized Multi-Cancer Detection

Mon, 12 Jan 2026 Yahoo! Finance

Dyno Therapeutics Launches Dyno-yp2, a Top-Performing TfR1-Mediated AAV Capsid, to Further Diversify CNS Delivery Portfolio

Thu, 8 Jan 2026 Business Wire

EpiBiologics Closes $107M Series B to Advance Pipeline of Novel Bispecific Antibodies to Selectively Degrade Extracellular Protein Targets in Oncology and Immunology

Wed, 7 Jan 2026 ir.cyclerion.com

Cyclerion Therapeutics Announces Strategic Agreement with Medsteer and Progress Toward Initiating Phase 2 Proof-of-Concept Study for CYC-126

Mon, 29 Dec 2025 BiotechTV

BioVenture VoiCes Episode 31: Polaris Partners' Amy Schulman

Thu, 11 Dec 2025 Healthcare Dive

Ex-Pfizer executive joins Elevance’s board as insurer pursues pharmacy experience

Tue, 9 Dec 2025 pathai.com

PathAI's AIM-MASH AI Assist Becomes First AI-Powered Pathology Tool to Receive FDA Qualification for MASH Clinical Trials

Tue, 9 Dec 2025 BioSpace

Kallyope Announces Positive Results from Phase 2b Study of Elismetrep for the Acute Treatment of Migraine

Fri, 5 Dec 2025 PR Newswire

Freenome and Perceptive Capital Solutions Corp Announce Business Combination Agreement to Create a Publicly Listed Company Transforming Blood-Based Multi-Cancer Detection through an AI/ML-Enabled Multiomics Platform

Thu, 4 Dec 2025 Business Wire

Sunbird Bio Presents New Clinical Data Supporting the Accuracy of its Blood-Based Alpha-Synuclein Assay for Parkinson’s Disease Detection

Wed, 3 Dec 2025 GlobeNewswire

Larkspur Biosciences Begins Dosing in Clinical Study of LRK-4189, a First-in-Class Targeted Protein Degrader

Tue, 2 Dec 2025 Business Wire

Podimetrics Unveils Provider Insights Report to Prevent Diabetic Foot Ulcers and Reduce Amputations

Fri, 21 Nov 2025 FierceBiotech

Roche inks $200M+ licensing pact for Freenome's cancer screening blood tests

Thu, 20 Nov 2025 PR Newswire

Cohere Health Ranked Among North America's Fastest-Growing Companies on the 2025 Deloitte Technology Fast 500™

Mon, 17 Nov 2025 Associated Press

Ankyra Therapeutics Announces First Patient Dosed in Phase 1b Trial Evaluating First-in-Class Anchored Immunotherapy in Combination with Immune Checkpoint Blockade in Patients with Lung Cancer

Wed, 12 Nov 2025 BioSpace

Dyno Therapeutics and Trisk Bio Announce Strategic Manufacturing Partnership Through Expanded Frontiers Program

Mon, 10 Nov 2025 Yahoo! Finance

Muna Therapeutics Announces First Subjects Dosed in Phase 1 Trial of Novel Oral TREM2 Agonist for Early Alzheimer's Disease

Thu, 6 Nov 2025 GlobeNewswire

Noema Pharma Announces Phase 2a Study Results with Cendifensine in Women with Vasomotor Symptoms (Hot Flashes) Due to Menopause

Tue, 4 Nov 2025 Yahoo! Finance

Sovato raises Series B funds to advance remote robotic surgery platform